Maize and blue graphic of a vaccine.

Exploring the cost-effectiveness of RSV vaccines in older adults

Q&A with David Hutton

David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).

Lorem ipsum

Social Distancing: Data Models for a Model Response to an Outbreak

Q&A with Peter Song

Biostatistics expert Peter Song and team have created a tool to assess the effectiveness of preventive measures in the fight against the COVID-19, still a new disease with many unknowns. The model lets us compare the impact of different levels of intervention so different locales can develop better strategies and policies to flatten the coronavirus curve.